| 000 -LEADER |
|---|
| fixed length control field |
00669nam a2200217Ia 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220314092620.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
180712s9999 xx 000 0 und d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780702042942 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.1 |
| Author Mark |
CLI |
| DDC Edition number |
23 |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Walker, Roger., ed. |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
CLINICAL Pharmacy and Therapeutics / |
| Statement of responsibility, etc. |
edited by Roger Walker and Cate Whittlesea |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
5th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Edinburgh |
| Name of publisher, distributor, etc. |
Churchill Livingstone |
| Date of publication, distribution, etc. |
2012 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiii, 983 p. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Includes appendix, glossary and index. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Clinical pharmacy |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Therapeutics |
| 9 (RLIN) |
17270 |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| 9 (RLIN) |
55861 |
| Personal name |
Walker, Roger |
| Role |
Editor |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| 9 (RLIN) |
130480 |
| Personal name |
Whittlesea , Cate |
| Role |
Editor |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| item type |
Books in Reference (R) |
